Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Other financing activities (2016 - 2024)

Aethlon Medical (AEMD) has disclosed Other financing activities for 3 consecutive years, with $310674.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Other financing activities changed N/A year-over-year to $310674.0, compared with a TTM value of $638399.0 through Jun 2024, changed N/A, and an annual FY2024 reading of $400002.0, down 78.69% over the prior year.
  • Other financing activities was $310674.0 for Q2 2024 at Aethlon Medical, up from $4651.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $310674.0 in Q2 2024 and bottomed at $310674.0 in Q2 2024.